Found: 25
Select item for more details and to access through your institution.
Deucravacitinib: A Novel TYK2 Inhibitor for the Treatment of Moderate-to-Severe Psoriasis.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 156, doi. 10.1177/24755303231201336
- By:
- Publication type:
- Article
Serum Adiponectin Levels as an Independent Marker of Severity of Psoriasis: A Cross-Sectional Analysis.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 148, doi. 10.1177/24755303231199995
- By:
- Publication type:
- Article
Corrigendum to Dosage Adjustments in Patients With Psoriasis on Etanercept: A Retrospective Chart Review.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Prevalence of Utilization Management Policies Among the Psoriatic Disease Community: Results From the 2019 National Psoriasis Foundation Advocacy Survey.
- Published in:
- 2023
- Publication type:
- Correction Notice
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 179, doi. 10.1177/24755303231195967
- By:
- Publication type:
- Article
A Systematic Review of Follicular Psoriasis: A Unique but Under-Recognized Entity.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 141, doi. 10.1177/24755303231196567
- By:
- Publication type:
- Article
Corrigendum to Treatment of Palmoplantar Pustulosis Using Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion: A Case Report.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Assessing the Effect of Demographic Background on Barriers to Seek Medical Attention for Psoriasis.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Biologic Treatment of 4 HIV-Positive Patients: A Case Series and Literature Review.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Tofacitinib for the Treatment of Refractory Palmoplantar Psoriasis: A Case Series.
- Published in:
- 2023
- Publication type:
- Correction Notice
Decrypting Skin Microbiome in Psoriasis: Current Status.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 166, doi. 10.1177/24755303231194293
- By:
- Publication type:
- Article
Corrigendum to Remission of Recalcitrant Psoriasis on Combined Biologic Therapy With Infliximab and Ustekinumab.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Tildrakizumab Inadequate Responders Switching to an Alternative IL-23 Inhibitor: A Case Series.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Retrospective Analysis in Patients With Moderate to Severe Plaque Psoriasis Treated With Tildrakizumab: Real-Life Clinical Data.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Antibody Response to BNT162b2 Vaccine in Immune Modifiers–Treated Psoriatic Patients.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Nail Changes in Psoriasis: Correlation Between Onychoscopy and NAPSI Scoring.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Acute Respiratory Distress Syndrome in a Carrier of an Interleukin-36 Receptor Antagonist Mutation With Generalized Pustular Psoriasis.
- Published in:
- 2023
- Publication type:
- Correction Notice
Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities.
- Published in:
- 2023
- Publication type:
- Correction Notice
Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 134, doi. 10.1177/24755303231186405
- By:
- Publication type:
- Article
Correlation Between Insulin Resistance and Psoriatic Arthritis Disease Activity: A Cross-Sectional Study.
- Published in:
- Journal of Psoriasis & Psoriatic Arthritis, 2023, v. 8, n. 4, p. 129, doi. 10.1177/24755303231180508
- By:
- Publication type:
- Article